Pregled bibliografske jedinice broj: 1044431
Neoangiogenesis and microvascular density in myelodysplastic syndrome – a single center experience
Neoangiogenesis and microvascular density in myelodysplastic syndrome – a single center experience // Molecular and experimental biology in medicine, 2 (2019), 2; 40-50 doi:10.33602/mebm.2.2.7 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1044431 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Neoangiogenesis and microvascular density in
myelodysplastic syndrome – a single center
experience
Autori
ŠkrtiĆ, Anita ; Gredelj-Šimec, Njetočka ; Kardum-Skelin, Ika ; Lovrić, Eva ; Muzinic, Darija ; Gašparov, Slavko ; Ostojić Kolonić, Slobodanka.
Izvornik
Molecular and experimental biology in medicine (2584-671X) 2
(2019), 2;
40-50
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
myelodysplastic syndrome ; microvascular density ; neoangiogenesis
Sažetak
Angiogenesis has a significant part in the pathogenesis of hematological malignancies, such as leukemia and myelodysplastic syndromes (MDS). We evaluated the relationship between morphometric, morphological and clinical features of MDS. Blood vessels of 31 newly diagnosed MDS bone marrow biopsies were immunohistochemically analyzed using CD34 and compared with 8 controls and 13 chronic myelomonocytic leukemias (CMML). MDS were categorized into three risk groups: low-, intermediate- and high- risk MDS. Microvascular density (MVD) and major and minor axis length were analyzed using digital image analysis. Overall, MDS had significantly higher MVD and lower minor axis values than the control group and CMML. High- risk MDS had significantly higher MVD compared to the controls, while all MDS risk groups had lower minor axis values than the control group. Increased minor and major axis values were prognostic predictors of shorter overall survival in all MDS risk groups and CMML patients. In conclusion, angiogenesis presents one of the essential factors in MDS pathogenesis and progression characterized by descriptive marrow microvascular network transformation. The size- related features are powerful indicators of survival in MDS patients.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
IP-2016-06-5842 - Prognostička vrijednost i dinamika cirkulirajuće mikroRNA u visokorizičnom mijelodisplastičnom sindromu liječenom 5-azacitidinom (MDSmicroRNA) (Ostojić Kolonić, Slobodanka, HRZZ - 2016-06) ( CroRIS)
Ustanove:
Klinička bolnica "Merkur",
Medicinski fakultet, Zagreb,
Zdravstveno veleučilište, Zagreb,
Akademija medicinskih znanosti
Profili:
Slavko Gašparov
(autor)
Ika Kardum-Skelin
(autor)
Njetočka Gredelj Šimec
(autor)
Slobodanka Ostojić Kolonić
(autor)
Eva Lovrić
(autor)
Anita Škrtić
(autor)